http://www.gilead.com
Gilead Sciences, Inc. Company Intro
Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.
Industry
Healthcare
Gilead Sciences, Inc. Headquaters
333 Lakeside Drive
Foster City,94404
United States
Gilead Sciences, Inc. Share price
17 May 2023 13:15 GMT
$79.77
1.39 (1.77 %)
Gilead Sciences, Inc. Market cap
$97.692 B
WMC RANKING
2024
Gilead Sciences, Inc. # 7
Drug Manufacturers—GeneralLatest Gilead Sciences, Inc. News
12 Feb 2024
Gilead Buying Liver Disease Drugmaker CymaBay For $4.3B
Gilead Sciences Inc. said Monday that it has agreed to purchase liver disease-focused clinical-stage biopharmaceutical company CymaBay Therapeutics Inc. for...
12 Feb 2024
Why Gilead Sciences Is Buying CymaBay Therapeutics for $4.3 Billion
Gilead Sciences is buying CymaBay Therapeutics, giving Gilead access to CymaBay's lead treatment for liver disease. Gilead will pay $4.3 billion or $32.50...
12 Feb 2024
Gilead to buy 'greatest biotech comeback' CymaBay for $4.3 billion - San Francisco Business Times
An activist hedge fund a few years ago wanted to liquidate 36-year-old CymaBay, which has burned through around $1 billion.
WMC Market Score
WMC Market to Revenue Score
Gilead Sciences, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Gilead Sciences, Inc. | USD | $25,564,000 | $10,220,000 | $301,000 | $976,920B | 7 |
| Johnson & Johnson | USD | $84,214,000 | $35,070,000 | $15,115,000 | $4,140,820B | 1 |
| AbbVie Inc. | USD | $50,195,000 | $19,406,000 | $5,099,000 | $2,528,050B | 2 |
| Merck & Co., Inc. | USD | $48,017,000 | $24,360,000 | $7,027,000 | $2,948,250B | 3 |
| Pfizer Inc. | USD | $46,407,000 | $25,063,000 | $11,138,000 | $2,079,450B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Gilead Sciences, Inc. Social Followers vs Top 4 Industry Competitors
Gilead Sciences, Inc. Post vs Top 4 Industry Competitors
Gilead Sciences, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Gilead Sciences, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Gilead Sciences, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Gilead Sciences, Inc. | 30.36 | 2.02 | 0.03 | 0 | 0 | 0 | 1.01 |
| Johnson & Johnson | 100 | 100 | 3.21 | 100 | 0 | 0 | 100 |
| AbbVie Inc. | 59.60 | 64.55 | 100 | 0 | 0 | 0 | 80.98 |
| Merck & Co., Inc. | 57.02 | 21.69 | 35.91 | 0 | 0 | 0 | 28.35 |
| Pfizer Inc. | 55.11 | 55.18 | 94.82 | 0 | 0 | 0 | 73.81 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
